EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Congenital Hyperinsulinemic Hypoglycemia With a New HADH Mutation and Pancreatic Overexpression of GLP-1 Receptors

Andrea Widmer iD, Urs Zumsteg, Gabor Szinnai iD, Isabel Filges, Stephanie Meier, Julie De Geyter, Kwadwo Antwi, Damian Wild iD, Jean-Marc Nuoffer, Emanuel Christ iD

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgaf423 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Andrea Widmer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes, and Metabolism, University Hospital Basel, Basel CH-4031, Switzerland. Hauptthemen laut MEDLINE: Congenital Hyperinsulinism, Mutation, Glucagon-Like Peptide-1 Receptor, Pancreas. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Desirée and Niels Yde Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The most common cause of endogenous hyperinsulinemic hypoglycemia in neonates [congenital hyperinsulinemic hypoglycemia (CHH)] is different monogenic forms of gene mutations. About 50% of the mutations are known. We present a new mutation within the short-chain L-3-hydroxyacyl-CoA dehydrogenase (HADH) gene causing CHH in 2 related patients.

Methods

The course of 2 consanguineous patients with CHH are presented with a follow-up of >30 years. NextSeq 500 sequencing was performed and confined on known genes with autosomal recessive inheritance, namely ABCC8 (MANE Select: NM_00352.6), HADH (MANE Select: NM_005327.7), and KCNJ11 (MANE Select: NM_00525.4). Acylcarnitine profiles were measured and 68Ga-DOTA exendin positron emission tomography/computer tomography was performed.

Results

CHH was diagnosed in both patients in the neonatal period. A therapy with diazoxid was initiated, which initially stabilized the disease in both children. With advancing age, more hypoglycemic events occurred with an increase in carbohydrate intake, leading to obesity in both patients. In addition to diazoxide, somatostatin analogues were successfully added in adulthood. A genetic analysis documented a new homozygote mutation in the HADH gene (HADH-variant c.796G > T). An acylcarnitine profile showed an increased plasma butyryl-carnitine, consistent with a dysfunction of the HADH enzyme. 68Gallium-DOTA-exendin showed an increased uptake in the whole pancreas in both patients.

Conclusion

Clinical presentation, biochemical workup, and therapeutical response to diazoxide and somatostatin analogues are consistent with previous reports of HADH mutations. The overexpression of glucagon-like peptide 1 receptors in this context warrants further research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Congenital HyperinsulinismMutationGlucagon-Like Peptide-1 ReceptorPancreasHumansMaleFemaleInfant, NewbornDiazoxideInfant

Stichwörter der Autor:innen

GLP-1 receptor imagingHADH mutationcongenital hyperinsulinemic hypoglycemia

Substanzen

Glucagon-Like Peptide-1 ReceptorDiazoxideGLP1R protein, human

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes, and Metabolism, University Hospital Basel, Basel CH-4031, Switzerland.
  • Division of Endocrinology, Diabetes, and Metabolism, University Children's Hospital Basel, Basel CH-4031, Switzerland.
  • Medical Genetics, Institute of Medical Genetics and Pathology, University Hospital Basel, Basel CH-4031, Switzerland.
  • Division of Nuclear Medicine, University Hospital Basel, Basel CH-4031, Switzerland.
  • Division of Laboratory Medicine, University Hospital Berne, Inselspital, Bern CH-3010, Switzerland.
  • University Children's Hospital, University Hospital Bern, Inselspital, Bern CH-3010, Switzerland.

ORCID-Profile: Andrea Widmer, Gabor Szinnai, Damian Wild, Emanuel Christ

Förderung

  • Swiss National Science Foundation
  • Desirée and Niels Yde Foundation

Zitieren

APA

Widmer, A., Zumsteg, U., Szinnai, G., Filges, I., Meier, S., De Geyter, J., Antwi, K., Wild, D., Nuoffer, J. M., & Christ, E. (2026). Congenital Hyperinsulinemic Hypoglycemia With a New HADH Mutation and Pancreatic Overexpression of GLP-1 Receptors. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf423

Vancouver

Widmer A, Zumsteg U, Szinnai G, Filges I, Meier S, De Geyter J, et al. Congenital Hyperinsulinemic Hypoglycemia With a New HADH Mutation and Pancreatic Overexpression of GLP-1 Receptors. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf423

BibTeX
@article{Widmer2026,
  author = {Widmer, Andrea and Zumsteg, Urs and Szinnai, Gabor and Filges, Isabel and Meier, Stephanie and De Geyter, Julie and Antwi, Kwadwo and Wild, Damian and Nuoffer, Jean-Marc and Christ, Emanuel},
  title = {Congenital Hyperinsulinemic Hypoglycemia With a New HADH Mutation and Pancreatic Overexpression of GLP-1 Receptors},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgaf423}
}
Kostenlos starten →